C/EBPβ is stabilized and activated by S-glutathionylation in adipocytes [53] and may, therefore, be one of the targets by which Glrx decreases inflammatory mediators in NASH. The gene discussed is CEBPB; the disease is metabolic dysfunction-associated steatohepatitis.